Supportively, redressing lipid metabolism through factors, such as AMPK, PPARα/PGC1α, Hif1-α, VLCAD, and PLIN2, has been proved effective to prevent AF, exemplifying metabolic modulation as a potential therapeutic strategy for AF (Harada et al., 2017). Here, HIF1A is linked to atrial fibrillation.